🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
High risk MDS (Myelodysplastic Syndrome) patients will be treated with SGI-...
Status
Unknown
Location
CHU d'Angers
Start Date
2018-11
Trial ID
NCT03454984
Treatments Being Tested
Allo-hsct is potentially curative method of treatment for children and adol...
Status
Completed
Location
RM Gorbacheva Research Institute
Start Date
2021-04-01
Trial ID
NCT05009719
Treatments Being Tested
Unmanipulated allogenic peripheral blood stem cell transplantation (allo-PB...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2019-01
Trial ID
NCT03771222
Treatments Being Tested
Hematopoietic stem cell transplantation (HSCT) is one of the best, and some...
Status
Completed
Location
Lanzhou General Hospital of Lanzhou Command
Start Date
2009-07
Trial ID
NCT01455272
Treatments Being Tested
This is a new platform in non-myeloablative allogeneic stem cell transplant...
Status
Completed
Location
Abramson Cancer Center at University of Pennsylvania
Start Date
2007-04
Trial ID
NCT00374933
Pilot, multicentric, open-label, single-arm, phase I-II clinical trial to e...
Status
Completed
Location
Hospital Universitari Germans Trias i Pujol
Start Date
2014-07
Trial ID
NCT02328885
Treatments Being Tested
This study is being done to assess the safety and determine the maximum tol...
Status
Recruiting
Location
UW Carbone Cancer Center
Start Date
2026-02-26
Trial ID
NCT07285668
Treatments Being Tested
CAR-T therapy has evolved as a pivotal treatment for relapsed/refractory (R...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2025-09-01
Trial ID
NCT07087847
Treatments Being Tested
The primary objective of this proposal is to conduct the first-in-human ran...
Status
Not Yet Recruiting
Location
The University of Arizona Cancer Center
Start Date
2026-10-31
Trial ID
NCT07254793
Donor lymphocyte infusion (DLI) based on minimal residual disease (MRD) has...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07319793
Treatments Being Tested